SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-410232
Filing Date
2014-11-13
Accepted
2014-11-13 07:21:07
Documents
3
Period of Report
2014-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819021d8k.htm 8-K 12774
2 EX-99.1 d819021dex991.htm EX-99.1 55031
3 GRAPHIC g819021g22a68.gif GRAPHIC 3693
  Complete submission text file 0001193125-14-410232.txt   74184
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 141216289
SIC: 2834 Pharmaceutical Preparations